Anti-Acne Cosmetics Market by Product Type (Cream & Lotion, Gel, Mask), Treatment Type (Prevention, Repair, Treatment), Formulation, Price Range, Age Group, Skin Type, End User, Distribution Channel - Global Forecast 2025-2032
Description
The Anti-Acne Cosmetics Market was valued at USD 5.73 billion in 2024 and is projected to grow to USD 6.37 billion in 2025, with a CAGR of 12.12%, reaching USD 14.34 billion by 2032.
A high-level orientation to current consumer, formulation, and regulatory forces reshaping anti-acne cosmetics and defining new strategic priorities
The anti-acne cosmetics landscape is undergoing a blend of scientific refinement and consumer-driven evolution that is reshaping product development priorities and commercial strategies. Consumers increasingly demand formulations that balance efficacy with tolerability, and they expect transparency around active ingredients, sustainability credentials, and dermatological validation. Concurrently, industrial actors are responding with targeted formulation platforms that integrate proven actives alongside calming botanicals, while leveraging advanced delivery systems to improve skin compatibility and user experience.
These shifts are producing new demand signals across distribution channels and demographic cohorts, requiring brands to refine positioning and communication. As regulatory scrutiny tightens around certain actives and claims, manufacturers and marketers must align product innovation with evidence-based claims and robust safety data. In the following sections, the report explores how these converging forces influence product portfolios, channel strategies, consumer segments, and regulatory engagement, setting the stage for pragmatic recommendations that support resilient growth.
How converging advances in dermatological science, consumer skin wellness priorities, and digital engagement are fundamentally altering product development and growth strategies
Transformative shifts in the anti-acne cosmetics space are anchored in three interrelated trends: the maturation of active ingredient science, the mainstreaming of skin-first wellness narratives, and the digital redefinition of consumer discovery and purchase behavior. Advances in dermatological research have clarified the mechanisms of common actives, prompting refinements in concentration, vehicle selection, and combined modality approaches that improve tolerability without sacrificing performance. At the same time, consumers are prioritizing long-term skin health, which elevates prevention and repair propositions alongside acute treatment claims.
Digital ecosystems have accelerated these transformations by enabling hyper-targeted education, influencer-mediated validation, and rapid iterative feedback that informs product reformulation cycles. Together, these dynamics are compelling incumbents to adopt evidence-centric marketing, integrate cross-disciplinary formulation expertise, and strengthen post-market surveillance to maintain consumer trust. As such, organizations that can blend scientific credibility with compelling digital narratives will be positioned to capture heightened attention and loyalty across diverse consumer cohorts.
Anticipatory adjustments to sourcing, production footprint, and pricing strategy prompted by new tariff policies and their cascading effects across supply chains and retail dynamics
The imposition of new tariff measures within the United States during 2025 introduces material considerations for supply chain configuration, cost pass-through, and competitive positioning for brands and suppliers operating in the anti-acne cosmetics category. Increased duties on certain imported inputs or finished goods can incentivize nearshoring of critical manufacturing steps, greater vertical integration, and re-evaluation of ingredient sourcing strategies to preserve margin and maintain price competitiveness. In response, private label manufacturers and brand owners are assessing alternative suppliers, reformulating to reduce dependence on tariff-affected components, or accelerating domestic capacity expansions where feasible.
Importantly, tariff-driven cost pressures interact with evolving retailer expectations and consumer price sensitivity, so firms must balance short-term margin protection with longer-term brand equity considerations. Transparent communication about reformulation rationale and supply chain investments can mitigate consumer concern, while strategic promotions and channel-specific pricing can preserve distribution strength. Ultimately, proactive scenario planning that models procurement alternatives, lead-time variability, and contract renegotiation outcomes will be essential for maintaining operational resilience under the changed trade environment.
Segment-level clarity across product formats, distribution routes, consumer demographics, treatment objectives, formulation philosophies, price tiers, age cohorts, and skin types to guide precise commercial targeting
Segmentation insights reveal distinct product and consumer clusters that inform precise commercial tactics and formulation roadmaps. Based on product type, portfolios span Cream & Lotion formats differentiated into mattifying and moisturizing variants, Gel formats that include oil-free gel and soothing gel options, Mask, Serum, and Soap & Cleanser, each serving discrete application occasions and consumer preferences. Distribution channel dynamics range from e-commerce channels delivered via mobile apps and web portals to brick-and-mortar presences in pharmacy and drugstore networks, specialty stores, and supermarket and hypermarket environments, with each route demanding tailored merchandising and sampling strategies.
End-user segmentation identifies Men, Teen, Unisex, and Women audiences, necessitating gender- and life-stage-informed messaging and texture preferences. Treatment-type distinctions between Prevention, Repair, and Treatment influence product claims and regimen positioning, while formulation choices split across Chemical and Natural Botanical approaches; chemical actives such as benzoyl peroxide and salicylic acid contrast with botanical options like aloe vera and tea tree oil, requiring differentiated safety and efficacy narratives. Price range segmentation includes Luxury with ultra-luxury tiers, Premium subdivided into high and mid-premium, and Mass offerings, which together define promotional cadence and packaging investment. Age-group perspectives distinguish Adult cohorts-mature adult and young adult-alongside Middle Aged & Above and Teen groups, while skin-type differentiation across Combination types including dry combination and oily combination, Normal, Oily, and Sensitive skin drives texture, pH, and delivery system decisions.
A regional perspective on how consumer preferences, regulatory landscapes, and retail ecosystems across three major global regions are shaping product strategies and go-to-market decisions
Regional insights underscore heterogeneous demand drivers and regulatory contexts that require differentiated market approaches. In the Americas region, consumer emphasis on clinically proven actives and dermatological endorsements is strengthening pharmacies and e-commerce as critical discovery and purchase channels, while rising consumer interest in clean formulations is influencing product portfolios. Europe, Middle East & Africa presents a mosaic of regulatory regimes and ingredient restrictions that necessitate agile compliance frameworks, but it also offers opportunities for premium positioning in markets that value natural botanicals and sustainably sourced ingredients.
Asia-Pacific is characterized by rapid product innovation cycles, strong influence of beauty technology trends, and high digital commerce penetration, which amplifies the importance of localized product attributes and influencer-led education. Across regions, companies that combine regulatory foresight with localized marketing and distribution orchestration will be better placed to capitalize on divergent consumer priorities and competitive dynamics.
A synthesis of competitive behaviors showing how legacy brands, clinical specialists, and digitally native challengers are vying for differentiation through science, transparency, and omnichannel reach
Competitive dynamics in anti-acne cosmetics are being shaped by a mix of multinational brands, specialized dermatological players, and agile indie innovators that emphasize targeted science, formulation transparency, and direct-to-consumer engagement. Established players leverage scale in R&D, regulatory affairs, and distribution partnerships to maintain visibility in mass and premium channels, while specialist brands often capture niche authority through clinical collaborations, dermatologist endorsements, and focused educational content. Meanwhile, digitally native entrants utilize rapid product iteration, influencer partnerships, and subscription models to accelerate trial and build direct relationships with consumers.
In this environment, strategic differentiation is underpinned by demonstrable ingredient expertise, robust safety and tolerability data, and strong omnichannel capabilities. Companies investing in cross-functional teams that integrate formulation scientists, regulatory experts, and digital marketers will navigate competitive pressures more successfully. Additionally, partnerships with contract manufacturers and ingredient suppliers that offer flexible production runs and regulatory support are proving instrumental for both market incumbents and challengers seeking to scale without sacrificing quality.
Practical and prioritized strategic initiatives that accelerate responsible innovation, fortify supply chains, enhance omnichannel execution, and strengthen clinical and consumer trust
Actionable recommendations for industry leaders focus on aligning product innovation, channel strategies, and regulatory readiness with evolving consumer expectations. First, prioritize formulation platforms that combine clinically validated actives with calming botanicals to address both efficacy and tolerability; invest in head-to-head tolerability assessments and consumer-reported outcomes to support clear claims. Second, optimize omnichannel presence by integrating mobile-first e-commerce experiences with in-store education and sampling initiatives that reinforce regimen adoption and repeat purchase behavior.
Third, proactively address tariff and supply-chain variability by diversifying supplier bases, exploring nearshoring options, and negotiating flexible manufacturing agreements that preserve responsiveness. Fourth, tailor portfolio segmentation to reflect nuanced consumer clusters-age, skin type, price sensitivity, and treatment objective-so that marketing investment drives higher conversion. Finally, strengthen post-market surveillance and claim substantiation through real-world evidence collection and dermatologist partnerships to build trust and reduce regulatory friction. Taken together, these actions create both defensive resilience and offensive growth potential in a competitive and evolving market.
A rigorous mixed-methods approach combining expert interviews, consumer behavior analysis, clinical literature review, regulatory mapping, and scenario planning to inform strategic insights
The research methodology guiding these insights combined qualitative and quantitative evidence streams to ensure a comprehensive understanding of category dynamics and stakeholder perspectives. Primary inputs included structured interviews with dermatologists, brand leaders, formulators, and retail category managers, supplemented by consumer ethnography and usage pattern analysis to capture real-world regimen behaviors. Secondary sources encompassed peer-reviewed dermatological literature, regulatory guidance documents, and public corporate disclosures to triangulate claims and assess ingredient risk profiles.
Data synthesis employed cross-validation techniques to reconcile divergent signals across channels and geographies, and scenario analysis was used to evaluate the operational implications of tariff changes and supply-chain disruptions. Emphasis was placed on triangulating consumer sentiment with clinical tolerability evidence to ensure that commercial recommendations are both market-responsive and scientifically grounded. Throughout, methodological rigor prioritized transparency of assumptions, reproducibility of analytic steps, and clear documentation of data provenance.
A forward-looking synthesis emphasizing the integration of clinical rigor, consumer centricity, and operational agility as the foundation for sustainable leadership in anti-acne cosmetics
In conclusion, the anti-acne cosmetics space is at an inflection point where scientific refinement, consumer expectations for skin wellness, and evolving trade and retail dynamics converge to redefine competitive advantage. Firms that invest in evidence-backed formulations, articulate clear benefit-risk profiles, and deploy nimble commercial strategies across both digital and physical channels will better capture consumer trust and commercial momentum. Equally important is the need for operational flexibility to respond to tariff implications and supply-chain perturbations while maintaining consistent product quality and brand integrity.
Looking ahead, sustained success will depend on integrating clinical diligence with consumer-centric storytelling, and on building cross-functional capabilities that can rapidly translate new dermatological insights into market-ready offerings. Organizations that commit to these priorities will not only meet immediate category demands but also position themselves to lead in an increasingly sophisticated and outcomes-oriented skincare market.
Note: PDF & Excel + Online Access - 1 Year
A high-level orientation to current consumer, formulation, and regulatory forces reshaping anti-acne cosmetics and defining new strategic priorities
The anti-acne cosmetics landscape is undergoing a blend of scientific refinement and consumer-driven evolution that is reshaping product development priorities and commercial strategies. Consumers increasingly demand formulations that balance efficacy with tolerability, and they expect transparency around active ingredients, sustainability credentials, and dermatological validation. Concurrently, industrial actors are responding with targeted formulation platforms that integrate proven actives alongside calming botanicals, while leveraging advanced delivery systems to improve skin compatibility and user experience.
These shifts are producing new demand signals across distribution channels and demographic cohorts, requiring brands to refine positioning and communication. As regulatory scrutiny tightens around certain actives and claims, manufacturers and marketers must align product innovation with evidence-based claims and robust safety data. In the following sections, the report explores how these converging forces influence product portfolios, channel strategies, consumer segments, and regulatory engagement, setting the stage for pragmatic recommendations that support resilient growth.
How converging advances in dermatological science, consumer skin wellness priorities, and digital engagement are fundamentally altering product development and growth strategies
Transformative shifts in the anti-acne cosmetics space are anchored in three interrelated trends: the maturation of active ingredient science, the mainstreaming of skin-first wellness narratives, and the digital redefinition of consumer discovery and purchase behavior. Advances in dermatological research have clarified the mechanisms of common actives, prompting refinements in concentration, vehicle selection, and combined modality approaches that improve tolerability without sacrificing performance. At the same time, consumers are prioritizing long-term skin health, which elevates prevention and repair propositions alongside acute treatment claims.
Digital ecosystems have accelerated these transformations by enabling hyper-targeted education, influencer-mediated validation, and rapid iterative feedback that informs product reformulation cycles. Together, these dynamics are compelling incumbents to adopt evidence-centric marketing, integrate cross-disciplinary formulation expertise, and strengthen post-market surveillance to maintain consumer trust. As such, organizations that can blend scientific credibility with compelling digital narratives will be positioned to capture heightened attention and loyalty across diverse consumer cohorts.
Anticipatory adjustments to sourcing, production footprint, and pricing strategy prompted by new tariff policies and their cascading effects across supply chains and retail dynamics
The imposition of new tariff measures within the United States during 2025 introduces material considerations for supply chain configuration, cost pass-through, and competitive positioning for brands and suppliers operating in the anti-acne cosmetics category. Increased duties on certain imported inputs or finished goods can incentivize nearshoring of critical manufacturing steps, greater vertical integration, and re-evaluation of ingredient sourcing strategies to preserve margin and maintain price competitiveness. In response, private label manufacturers and brand owners are assessing alternative suppliers, reformulating to reduce dependence on tariff-affected components, or accelerating domestic capacity expansions where feasible.
Importantly, tariff-driven cost pressures interact with evolving retailer expectations and consumer price sensitivity, so firms must balance short-term margin protection with longer-term brand equity considerations. Transparent communication about reformulation rationale and supply chain investments can mitigate consumer concern, while strategic promotions and channel-specific pricing can preserve distribution strength. Ultimately, proactive scenario planning that models procurement alternatives, lead-time variability, and contract renegotiation outcomes will be essential for maintaining operational resilience under the changed trade environment.
Segment-level clarity across product formats, distribution routes, consumer demographics, treatment objectives, formulation philosophies, price tiers, age cohorts, and skin types to guide precise commercial targeting
Segmentation insights reveal distinct product and consumer clusters that inform precise commercial tactics and formulation roadmaps. Based on product type, portfolios span Cream & Lotion formats differentiated into mattifying and moisturizing variants, Gel formats that include oil-free gel and soothing gel options, Mask, Serum, and Soap & Cleanser, each serving discrete application occasions and consumer preferences. Distribution channel dynamics range from e-commerce channels delivered via mobile apps and web portals to brick-and-mortar presences in pharmacy and drugstore networks, specialty stores, and supermarket and hypermarket environments, with each route demanding tailored merchandising and sampling strategies.
End-user segmentation identifies Men, Teen, Unisex, and Women audiences, necessitating gender- and life-stage-informed messaging and texture preferences. Treatment-type distinctions between Prevention, Repair, and Treatment influence product claims and regimen positioning, while formulation choices split across Chemical and Natural Botanical approaches; chemical actives such as benzoyl peroxide and salicylic acid contrast with botanical options like aloe vera and tea tree oil, requiring differentiated safety and efficacy narratives. Price range segmentation includes Luxury with ultra-luxury tiers, Premium subdivided into high and mid-premium, and Mass offerings, which together define promotional cadence and packaging investment. Age-group perspectives distinguish Adult cohorts-mature adult and young adult-alongside Middle Aged & Above and Teen groups, while skin-type differentiation across Combination types including dry combination and oily combination, Normal, Oily, and Sensitive skin drives texture, pH, and delivery system decisions.
A regional perspective on how consumer preferences, regulatory landscapes, and retail ecosystems across three major global regions are shaping product strategies and go-to-market decisions
Regional insights underscore heterogeneous demand drivers and regulatory contexts that require differentiated market approaches. In the Americas region, consumer emphasis on clinically proven actives and dermatological endorsements is strengthening pharmacies and e-commerce as critical discovery and purchase channels, while rising consumer interest in clean formulations is influencing product portfolios. Europe, Middle East & Africa presents a mosaic of regulatory regimes and ingredient restrictions that necessitate agile compliance frameworks, but it also offers opportunities for premium positioning in markets that value natural botanicals and sustainably sourced ingredients.
Asia-Pacific is characterized by rapid product innovation cycles, strong influence of beauty technology trends, and high digital commerce penetration, which amplifies the importance of localized product attributes and influencer-led education. Across regions, companies that combine regulatory foresight with localized marketing and distribution orchestration will be better placed to capitalize on divergent consumer priorities and competitive dynamics.
A synthesis of competitive behaviors showing how legacy brands, clinical specialists, and digitally native challengers are vying for differentiation through science, transparency, and omnichannel reach
Competitive dynamics in anti-acne cosmetics are being shaped by a mix of multinational brands, specialized dermatological players, and agile indie innovators that emphasize targeted science, formulation transparency, and direct-to-consumer engagement. Established players leverage scale in R&D, regulatory affairs, and distribution partnerships to maintain visibility in mass and premium channels, while specialist brands often capture niche authority through clinical collaborations, dermatologist endorsements, and focused educational content. Meanwhile, digitally native entrants utilize rapid product iteration, influencer partnerships, and subscription models to accelerate trial and build direct relationships with consumers.
In this environment, strategic differentiation is underpinned by demonstrable ingredient expertise, robust safety and tolerability data, and strong omnichannel capabilities. Companies investing in cross-functional teams that integrate formulation scientists, regulatory experts, and digital marketers will navigate competitive pressures more successfully. Additionally, partnerships with contract manufacturers and ingredient suppliers that offer flexible production runs and regulatory support are proving instrumental for both market incumbents and challengers seeking to scale without sacrificing quality.
Practical and prioritized strategic initiatives that accelerate responsible innovation, fortify supply chains, enhance omnichannel execution, and strengthen clinical and consumer trust
Actionable recommendations for industry leaders focus on aligning product innovation, channel strategies, and regulatory readiness with evolving consumer expectations. First, prioritize formulation platforms that combine clinically validated actives with calming botanicals to address both efficacy and tolerability; invest in head-to-head tolerability assessments and consumer-reported outcomes to support clear claims. Second, optimize omnichannel presence by integrating mobile-first e-commerce experiences with in-store education and sampling initiatives that reinforce regimen adoption and repeat purchase behavior.
Third, proactively address tariff and supply-chain variability by diversifying supplier bases, exploring nearshoring options, and negotiating flexible manufacturing agreements that preserve responsiveness. Fourth, tailor portfolio segmentation to reflect nuanced consumer clusters-age, skin type, price sensitivity, and treatment objective-so that marketing investment drives higher conversion. Finally, strengthen post-market surveillance and claim substantiation through real-world evidence collection and dermatologist partnerships to build trust and reduce regulatory friction. Taken together, these actions create both defensive resilience and offensive growth potential in a competitive and evolving market.
A rigorous mixed-methods approach combining expert interviews, consumer behavior analysis, clinical literature review, regulatory mapping, and scenario planning to inform strategic insights
The research methodology guiding these insights combined qualitative and quantitative evidence streams to ensure a comprehensive understanding of category dynamics and stakeholder perspectives. Primary inputs included structured interviews with dermatologists, brand leaders, formulators, and retail category managers, supplemented by consumer ethnography and usage pattern analysis to capture real-world regimen behaviors. Secondary sources encompassed peer-reviewed dermatological literature, regulatory guidance documents, and public corporate disclosures to triangulate claims and assess ingredient risk profiles.
Data synthesis employed cross-validation techniques to reconcile divergent signals across channels and geographies, and scenario analysis was used to evaluate the operational implications of tariff changes and supply-chain disruptions. Emphasis was placed on triangulating consumer sentiment with clinical tolerability evidence to ensure that commercial recommendations are both market-responsive and scientifically grounded. Throughout, methodological rigor prioritized transparency of assumptions, reproducibility of analytic steps, and clear documentation of data provenance.
A forward-looking synthesis emphasizing the integration of clinical rigor, consumer centricity, and operational agility as the foundation for sustainable leadership in anti-acne cosmetics
In conclusion, the anti-acne cosmetics space is at an inflection point where scientific refinement, consumer expectations for skin wellness, and evolving trade and retail dynamics converge to redefine competitive advantage. Firms that invest in evidence-backed formulations, articulate clear benefit-risk profiles, and deploy nimble commercial strategies across both digital and physical channels will better capture consumer trust and commercial momentum. Equally important is the need for operational flexibility to respond to tariff implications and supply-chain perturbations while maintaining consistent product quality and brand integrity.
Looking ahead, sustained success will depend on integrating clinical diligence with consumer-centric storytelling, and on building cross-functional capabilities that can rapidly translate new dermatological insights into market-ready offerings. Organizations that commit to these priorities will not only meet immediate category demands but also position themselves to lead in an increasingly sophisticated and outcomes-oriented skincare market.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
184 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Increasing use of postbiotic and probiotic formulations to balance skin microbiome in acne treatments
- 5.2. Adoption of sustainable and refillable packaging solutions driven by eco-conscious acne skincare consumers
- 5.3. Integration of AI-driven skin analysis tools to customize anti-acne regimens based on individual skin profiles
- 5.4. Surge in demand for clean-label anti-acne products free from sulfates, parabens, silicones and artificial dyes
- 5.5. Growth of teledermatology platforms offering remote acne diagnosis and customized prescription-strength treatments
- 5.6. Emergence of multi-targeted serums combining retinoids, salicylic acid and niacinamide for comprehensive acne control
- 5.7. Popularity of botanical extracts like tea tree oil, centella asiatica and bakuchiol in natural anti-acne formulations
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Anti-Acne Cosmetics Market, by Product Type
- 8.1. Cream & Lotion
- 8.1.1. Mattifying
- 8.1.2. Moisturizing
- 8.2. Gel
- 8.2.1. Oil Free Gel
- 8.2.2. Soothing Gel
- 8.3. Mask
- 8.4. Serum
- 8.5. Soap & Cleanser
- 9. Anti-Acne Cosmetics Market, by Treatment Type
- 9.1. Prevention
- 9.2. Repair
- 9.3. Treatment
- 10. Anti-Acne Cosmetics Market, by Formulation
- 10.1. Chemical
- 10.1.1. Benzoyl Peroxide
- 10.1.2. Salicylic Acid
- 10.2. Natural Botanical
- 10.2.1. Aloe Vera
- 10.2.2. Tea Tree Oil
- 11. Anti-Acne Cosmetics Market, by Price Range
- 11.1. Luxury
- 11.2. Mass
- 11.3. Premium
- 12. Anti-Acne Cosmetics Market, by Age Group
- 12.1. Adult
- 12.1.1. Mature Adult
- 12.1.2. Young Adult
- 12.2. Middle Aged & Above
- 12.3. Teen
- 13. Anti-Acne Cosmetics Market, by Skin Type
- 13.1. Combination
- 13.1.1. Dry Combination
- 13.1.2. Oily Combination
- 13.2. Normal
- 13.3. Oily
- 13.4. Sensitive
- 14. Anti-Acne Cosmetics Market, by End User
- 14.1. Men
- 14.2. Teen
- 14.3. Unisex
- 14.4. Women
- 15. Anti-Acne Cosmetics Market, by Distribution Channel
- 15.1. E Commerce
- 15.1.1. Mobile App
- 15.1.2. Web Portal
- 15.2. Pharmacy & Drugstore
- 15.3. Specialty Store
- 15.4. Supermarket & Hypermarket
- 16. Anti-Acne Cosmetics Market, by Region
- 16.1. Americas
- 16.1.1. North America
- 16.1.2. Latin America
- 16.2. Europe, Middle East & Africa
- 16.2.1. Europe
- 16.2.2. Middle East
- 16.2.3. Africa
- 16.3. Asia-Pacific
- 17. Anti-Acne Cosmetics Market, by Group
- 17.1. ASEAN
- 17.2. GCC
- 17.3. European Union
- 17.4. BRICS
- 17.5. G7
- 17.6. NATO
- 18. Anti-Acne Cosmetics Market, by Country
- 18.1. United States
- 18.2. Canada
- 18.3. Mexico
- 18.4. Brazil
- 18.5. United Kingdom
- 18.6. Germany
- 18.7. France
- 18.8. Russia
- 18.9. Italy
- 18.10. Spain
- 18.11. China
- 18.12. India
- 18.13. Japan
- 18.14. Australia
- 18.15. South Korea
- 19. Competitive Landscape
- 19.1. Market Share Analysis, 2024
- 19.2. FPNV Positioning Matrix, 2024
- 19.3. Competitive Analysis
- 19.3.1. Clinique Laboratories, LLC
- 19.3.2. Galderma Group
- 19.3.3. JMSR, Inc.
- 19.3.4. Johnson & Johnson Services, Inc.
- 19.3.5. KOSÉ Corporation
- 19.3.6. L’Oréal S.A.
- 19.3.7. Taro Pharmaceutical Industries Ltd.
- 19.3.8. The Mentholatum Company
- 19.3.9. Dr.Jart+ by Have & Be USA, Inc.
- 19.3.10. COSRX Inc.
- 19.3.11. SESDERMA USA LLC
- 19.3.12. Unilever PLC
- 19.3.13. HUM Nutrition Inc.
- 19.3.14. CP Skin Health Group, Inc.
- 19.3.15. Obagi Cosmeceuticals LLC
- 19.3.16. Colorescience, Inc.
- 19.3.17. Revision Skincare
- 19.3.18. The BeautyHealth Company
- 19.3.19. GLOWBIOTICS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
